Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in both an immunodeficient and immunocompetent animal model

✍ Scribed by A. Labrinidis; V. Liapis; S. Hay; D.M. Findlay; A. Evdokiou

• Book ID: 116321472
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 59 KB
• Volume: 44
• Category: Article
• ISSN: 8756-3282
• DOI: 10.1016/j.bone.2009.01.383